Syed Bilal Andrabi

Senior Researcher @University of Turku@ InFLAMES flagship,Turku, Finland.

[Syed Bilal Andrabi @bilal_ibu]

@nimivashi15 Safe travels nd have fun!!!

[Juan Melero-Martin @MeleroMartinLab]

New paper in #Angiogenesis from lab alum @R_Moreno_Luna shows SCI patient-derived vascular cells retain vasculogenic potential. Exciting translational work from his group in Spain.
https://t.co/WlHVivA9uK
#vascularbiology #stemcells #spinalcordinjury #labalumni

[Journal of Clinical Investigation @jclinicalinvest]

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver: https://t.co/eoJ3t32vDY

@DeanTang8 @RoswellPark provides a Commentary on Kaiyuan Liu et al. (https://t.co/YiJkFHYAgd)

[Syed Bilal Andrabi @bilal_ibu]

Amazing talk by Adrian Liston!!!!!

[Syed Bilal Andrabi @bilal_ibu]

Cldnt have expected better morning than this !!!

[Syed Bilal Andrabi @bilal_ibu]

Excited to share our new study uncovering the role of long noncoding RNA (lincRNAs) in human regulatory T-cell differentiation! This study reveals how lincRNAs impact immune function, paving the way for potential therapies for immune-related disorders.
https://t.co/pHoJZ42f9E

[Lahesmaa Group @LahesmaaGroup]

Happy to share our new paper showing that PIM kinases regulate early Th17 cell differentiation! Thank you for fruitful collaboration! @EloLab_fi @InFLAMES_Health @BioscienceTurku @SuomenAkatemia @SigridJuselius @https://www.sciencedirect.com/science/article/pii/S221112472301481X

[Immunity @ImmunityCP]

Online now: Intestinal microbiota-specific Th17 cells possess regulatory properties and suppress effector T cells via c-MAF and IL-10 https://t.co/MP0RqjQUro

[Waggoner Lab @LabWaggoner]

PIM kinases inhibit early human Th17 cell differentiation by suppressing key Th17 -related genes while promoting the expression of Th1 lineage-specific genes @CellReports
https://t.co/JZIiSayFV7

[Syed Bilal Andrabi @bilal_ibu]

#IUIS2023..Looking farward to some exciting talks #AmazingCapeTown

[Molecular Therapy Family of Journals @MolTherapy]

Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of Acute Myeloid Leukemia https://t.co/3MRfCtXEBN

[Syed Bilal Andrabi @bilal_ibu]

Thanks dear, indeed had a great time…

[Lahesmaa Group @LahesmaaGroup]

We are happy to share our new preprint: “HIC1 interacts with FOXP3 multi-protein complex: a novel mechanism to regulate human regulatory T cell differentiation and function.”
https://t.co/QYOtpggpLX
@InFLAMES_Health @Innodiagroup @HEDIMED2020 @SuomenAkatemia @SigridJuselius

[Tansu Yegen @TansuYegen]

Great concept that every business owner or manager should learn

[TurkuBioscience @BioscienceTurku]

Do you have plans on June 21? How about joining our online seminar by Prof. Liston? No participation costs & open for everyone. 👉register by June 20 https://t.co/dglzNJXuyU

[Syed Bilal Andrabi @bilal_ibu]

@ICGEB @dhirajverma @kvijayraghavan @DinakarMSalunke @GroupTumour @ItalyinIndia @IndiaDST @ICGEBBioenergy @ICGEBCapeTown @TBNTuberculosis Congratulations Sir!!!!!

[Syed Bilal Andrabi @bilal_ibu]

@nimivashi15 @moderna_tx Stay safe

[Syed Bilal Andrabi @bilal_ibu]

@nimivashi15 @sloan_kettering @yfortiss @miagarch Rise and shine!!!!

[Syed Bilal Andrabi @bilal_ibu]

@nimivashi15 How can you forget INDEED.

[Syed Bilal Andrabi @bilal_ibu]

@SanjeevSaGa Congratulations.....